Inclusive of all taxes
Ofpod O tablet by Flange Pharmaceuticals Private Limited is a potent combination antibiotic containing Cefpodoxime 200 mg and Ofloxacin 200 mg. This formulation is designed to combat a broad spectrum of bacterial infections effectively, including those resistant to conventional antibiotics. Cefpodoxime, a third-generation cephalosporin, disrupts bacterial cell wall synthesis, while Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV. Together, they offer a rapid onset of action and enhanced antibacterial coverage for the treatment of respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other susceptible bacterial infections. Ofpod O tablets ensure convenient oral dosing, promoting patient compliance. Flange Pharmaceuticals' commitment to quality and affordability positions Ofpod O as a reliable therapeutic option for healthcare providers seeking effective antibacterial treatment in the Indian market.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Cefpodoxime 200 mg and Ofloxacin 200 mg |
| Antibacterial Spectrum | Broad-spectrum including Gram-positive and Gram-negative bacteria |
| Mechanism of Action | Cefpodoxime inhibits bacterial cell wall synthesis; Ofloxacin inhibits bacterial DNA replication enzymes |
| Onset of Action | Rapid absorption enabling quick symptomatic relief |
| Dosage Form | Oral tablet |
| Indications | Respiratory tract infections, urinary tract infections, skin and soft tissue infections |
| Manufacturer | Flange Pharmaceuticals Private Limited |
| Compliance | Formulated to address antibiotic resistance challenges |
| Patient Convenience | Easy-to-administer tablet form for enhanced compliance |
| Market Availability | Available in Indian pharmaceutical market |
| Attributes | Description |
|---|---|
| Dosage Strength | Cefpodoxime 200 mg + Ofloxacin 200 mg per tablet |
| Formulation Type | Tablet |
| Packaging | Blister packs or bottles (specific packaging details may vary) |
| Storage Conditions | Store in a cool, dry place away from direct sunlight |
| Shelf Life | Typically 2 years from manufacturing date |
| Route of Administration | Oral |
| Therapeutic Class | Antibiotics - Combination |
| Pharmacological Classes | Cephalosporins (Cefpodoxime) and Fluoroquinolones (Ofloxacin) |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Cefpodoxime inhibits bacterial cell wall synthesis while Ofloxacin interferes with DNA replication enzymes in bacteria, providing a synergistic effect that broadens antibacterial coverage and overcomes certain resistant strains.
Ofpod O is formulated to treat a variety of bacterial infections including respiratory tract infections, urinary tract infections, and skin and soft tissue infections caused by susceptible bacteria.
Yes, Ofpod O’s dual mechanism addresses antibiotic resistance by targeting bacteria through two complementary pathways, making it effective against some resistant strains.
Ofpod O tablets should be stored in a cool, dry place away from direct sunlight to preserve their potency and shelf life.
Yes, Ofpod O is designed for rapid absorption, providing a quick onset of antibacterial action for faster symptomatic relief.
Country Of Origin: India
Flange Pharmaceuticals Private Limited, a leading player in the Indian pharmaceutical industry, has announced the launch of Ofpod O, a cutting-edge antibiotic combination tablet containing Cefpodoxime 200 mg and Ofloxacin 200 mg. This innovative formulation is poised to revolutionize the treatment of various bacterial infections.
Ofpod O is meticulously crafted to address the growing challenge of antibiotic resistance, a global health concern. The synergistic combination of Cefpodoxime and Ofloxacin provides broad-spectrum antibacterial activity, effectively targeting a wide range of pathogens.
Potent Combination: The unique blend of Cefpodoxime and Ofloxacin ensures optimal efficacy against a wide spectrum of bacteria.
Rapid Action: Designed for quick absorption and rapid onset of action, providing faster relief from infection symptoms.
Convenient Dosage: The tablet formulation offers a convenient and easy-to-administer dosage for patients.
With its strong research and development capabilities, Flange Pharmaceuticals is dedicated to delivering high-quality, affordable medicines to patients across India. The company is confident that Ofpod O will make a significant contribution to improving patient outcomes and public health.
Inclusive of all taxes
You Save: 0
Varanasi , India
Manufacturer, Brand Owner, Exporter, Wholesaler, Women Entrepreneur
